Newsroom

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for DT120 (lysergide) ODT. The designation was supported by the significant unmet medical need in MDD and results from the Company...

--(BUSINESS WIRE)--Cyber & AI experts from federal agencies and allied nations will explore issues impacting the nation and world at the Billington CyberSecurity Summit....

SOUTH BURLINGTON, Vt.--(BUSINESS WIRE)--BETA Technologies, Inc. (NYSE: BETA) (“BETA” or the “Company”), an aerospace and defense company, today announced its participation at the following upcoming investor conferences: On Thursday, September 10, 2026, Herman Cueto, chief financial officer, and Devon Rothman, head of investor relations and FP&A, will participate in a fireside chat at the Jefferies Global Industrials Conference at 9:30 a.m. ET. The Company will also participate in individual...

PALO ALTO, Calif.--(BUSINESS WIRE)--D-Wave quantum finalizes a definitive agreement with the U.S. department of commerce for up to $100 million to accelerate U.S. quantum leadership...

PROVIDENCE, R.I.--(BUSINESS WIRE)--United Natural Foods, Inc. (NYSE: UNFI) (the “Company” or “UNFI”) today reported financial results for the fourth quarter (13 weeks) and fiscal year (52 weeks) ended August 1, 2026. Fourth Quarter Fiscal 2026   Full Year Fiscal 2026 Net sales decreased 0.7% to $7.6 billion Net income of $35 million; Net income per diluted share (EPS) of $0.57 Adjusted EBITDA(1) increased 48.3% to $172 million Adjusted EPS(1) increased to $0.69 Net cash provided by operating ac...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Solstice Gold Corp. (TSXV: SGC) (“Solstice”, “we”, “our” or the “Company”) is pleased to report the closing of its previously announced private placement financing on September 4, 2026 for gross proceeds of approximately $650,000 through the issuance of 10,833,333 common shares (“Common Shares”) at a price of $0.06 per Common Share for gross proceeds of $650,000 (the “Private Placement”). The proceeds of the Private Placement will be used and are nec...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the company will utilize the remainder of its previously announced $2 billion share repurchase authorization. To complete the utilization, United Therapeutics today will enter into an Accelerated Share Repurchase (ASR) agreement with Citibank, N.A. (Citi) to repurchase the company’s common stock, for approximately $477.6 million. T...

BUFORD, Ga.--(BUSINESS WIRE)--OneWater Marine Inc. (NASDAQ: ONEW) ("OneWater" or the "Company") today announced that Jeffrey Lamkin has resigned from the Company's Board of Directors (the "Board"), effective as of the close of business on September 3, 2026, in order to focus on other professional interests. Mr. Lamkin’s departure was not due to any disagreement with the operations, policies or practices of the Company. Following the resignation, the Company's Board of Directors will consist of...

MCLEAN, Va.--(BUSINESS WIRE)--Red Cell Partners announces a one-year agreement with the Department of War’s Chief Digital and Artificial Intelligence Office (CDAO) with a ceiling of up to $100 million. The agreement pilots shared savings, a contracting framework in which vendors are paid only for the costs they eliminate and the outcomes they deliver. For nearly two years, Red Cell worked with CDAO and the Navy to define how the DoW could significantly reduce costs by improving efficiency throu...

SALT LAKE CITY--(BUSINESS WIRE)--Palladyne AI and FANUC America Announce Strategic Collaboration to Advance Intelligent Robotic Automation...